PD Dr. Christian Rothermundt
Leitender Arzt
Leitung Ambulatorium St.Gallen & Rorschach
Medizinische Onkologie und Hämatologie · Dept. I
[Weight loss and night sweats with unexpected tumor localization]
Oberholzer C, Sawatzki M, Rothermundt C. [Weight loss and night sweats with unexpected tumor localization]. Praxis 2007; 96:1911-4.
28.11.2007[Weight loss and night sweats with unexpected tumor localization]
28.11.2007Praxis 2007; 96:1911-4
Oberholzer C, Sawatzki M, Rothermundt Christian
Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy
Decker M, Rothermundt C, Holländer G, Tichelli A, Rochlitz C. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. The lancet oncology 2006; 7:693-4.
01.08.2006Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy
01.08.2006The lancet oncology 2006; 7:693-4
Decker Michael, Rothermundt Christian, Holländer Georg, Tichelli André, Rochlitz Christoph
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial
Rothermundt C, Hubner R, Ahmad T, Gibbens I, Keyzor C, Habeshaw T, Kaye S, Gore M. Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial. British journal of cancer 2006; 94:74-8.
16.01.2006Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial
16.01.2006British journal of cancer 2006; 94:74-8
Rothermundt Christian, Hubner R, Ahmad T, Gibbens I, Keyzor C, Habeshaw T, Kaye S, Gore M
Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance
Drach J, Ludwig H, Geissler K, Fiegl M, Jäger U, Haas O, Thalhammer R, Rothermundt C, Schuster J, Angerler J, Huber H. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 1995; 86:3915-21.
15.11.1995Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance
15.11.1995Blood 1995; 86:3915-21
Drach J, Ludwig H, Geissler K, Fiegl M, Jäger U, Haas O A, Thalhammer R, Rothermundt Christian, Schuster J, Angerler J, Huber H
Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization
Drach J, Jäger U, Gsur A, Rothermundt C, Fiegl M, Rosenthal F, Angerler J, Nowotny H, Schuster J, Heinz R. Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer research 1995; 55:3854-9.
01.09.1995Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization
01.09.1995Cancer research 1995; 55:3854-9
Drach J, Jäger U, Gsur A, Rothermundt Christian, Fiegl M, Rosenthal F, Angerler J, Nowotny H, Schuster J, Heinz R